List of Tables
    Table 1. Remicade Biosimilar CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Remicade Biosimilar Market Trends
    Table 3. Remicade Biosimilar Market Drivers
    Table 4. Remicade Biosimilar Market Challenges
    Table 5. Remicade Biosimilar Market Restraints
    Table 6. Global Remicade Biosimilar Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Remicade Biosimilar Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Remicade Biosimilar Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Remicade Biosimilar Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Remicade Biosimilar Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Remicade Biosimilar Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Remicade Biosimilar Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Remicade Biosimilar Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Remicade Biosimilar Sales Share by Manufacturer, 2017-2022
    Table 15. Global Remicade Biosimilar Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Remicade Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Remicade Biosimilar by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Remicade Biosimilar as of 2021)
    Table 18. Top Players of Remicade Biosimilar in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Remicade Biosimilar Product Type
    Table 20. Date of International Manufacturers Enter into Remicade Biosimilar Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Remicade Biosimilar Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Remicade Biosimilar Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Remicade Biosimilar Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Remicade Biosimilar Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Remicade Biosimilar Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Remicade Biosimilar Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Remicade Biosimilar Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Remicade Biosimilar Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Remicade Biosimilar Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Remicade Biosimilar Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Remicade Biosimilar Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Remicade Biosimilar Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Remicade Biosimilar Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Remicade Biosimilar Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Remicade Biosimilar Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Remicade Biosimilar Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Remicade Biosimilar Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Remicade Biosimilar Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Remicade Biosimilar Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Remicade Biosimilar Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Synthon Pharmaceuticals Corporation Information
    Table 43. Synthon Pharmaceuticals Description and Business Overview
    Table 44. Synthon Pharmaceuticals Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Synthon Pharmaceuticals Remicade Biosimilar Product
    Table 46. Synthon Pharmaceuticals Recent Development
    Table 47. LG Life Sciences Corporation Information
    Table 48. LG Life Sciences Description and Business Overview
    Table 49. LG Life Sciences Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. LG Life Sciences Product
    Table 51. LG Life Sciences Recent Development
    Table 52. Novartis (Sandoz) Corporation Information
    Table 53. Novartis (Sandoz) Description and Business Overview
    Table 54. Novartis (Sandoz) Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Novartis (Sandoz) Product
    Table 56. Novartis (Sandoz) Recent Development
    Table 57. Celltrion Corporation Information
    Table 58. Celltrion Description and Business Overview
    Table 59. Celltrion Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Celltrion Product
    Table 61. Celltrion Recent Development
    Table 62. Biocon Corporation Information
    Table 63. Biocon Description and Business Overview
    Table 64. Biocon Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Biocon Product
    Table 66. Biocon Recent Development
    Table 67. Hospira Corporation Information
    Table 68. Hospira Description and Business Overview
    Table 69. Hospira Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Hospira Product
    Table 71. Hospira Recent Development
    Table 72. Merck Serono (Merck Group) Corporation Information
    Table 73. Merck Serono (Merck Group) Description and Business Overview
    Table 74. Merck Serono (Merck Group) Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Merck Serono (Merck Group) Product
    Table 76. Merck Serono (Merck Group) Recent Development
    Table 77. Biogen idec Inc. Corporation Information
    Table 78. Biogen idec Inc. Description and Business Overview
    Table 79. Biogen idec Inc. Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Biogen idec Inc. Product
    Table 81. Biogen idec Inc. Recent Development
    Table 82. Genentech (Roche Group) Corporation Information
    Table 83. Genentech (Roche Group) Description and Business Overview
    Table 84. Genentech (Roche Group) Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. Genentech (Roche Group) Product
    Table 86. Genentech (Roche Group) Recent Development
    Table 87. Fosun Pharmaceutical Corporation Information
    Table 88. Fosun Pharmaceutical Description and Business Overview
    Table 89. Fosun Pharmaceutical Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. Fosun Pharmaceutical Product
    Table 91. Fosun Pharmaceutical Recent Development
    Table 92. Livzon Pharmaceutical Corporation Information
    Table 93. Livzon Pharmaceutical Description and Business Overview
    Table 94. Livzon Pharmaceutical Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 95. Livzon Pharmaceutical Product
    Table 96. Livzon Pharmaceutical Recent Development
    Table 97. Anke Biotechnology Corporation Information
    Table 98. Anke Biotechnology Description and Business Overview
    Table 99. Anke Biotechnology Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 100. Anke Biotechnology Product
    Table 101. Anke Biotechnology Recent Development
    Table 102. Hualan Biological Engineering Corporation Information
    Table 103. Hualan Biological Engineering Description and Business Overview
    Table 104. Hualan Biological Engineering Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 105. Hualan Biological Engineering Product
    Table 106. Hualan Biological Engineering Recent Development
    Table 107. Walvax Biotechnology Corporation Information
    Table 108. Walvax Biotechnology Description and Business Overview
    Table 109. Walvax Biotechnology Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 110. Walvax Biotechnology Product
    Table 111. Walvax Biotechnology Recent Development
    Table 112. Hisun Pharmaceutical Corporation Information
    Table 113. Hisun Pharmaceutical Description and Business Overview
    Table 114. Hisun Pharmaceutical Remicade Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 115. Hisun Pharmaceutical Product
    Table 116. Hisun Pharmaceutical Recent Development
    Table 117. Key Raw Materials Lists
    Table 118. Raw Materials Key Suppliers Lists
    Table 119. Remicade Biosimilar Customers List
    Table 120. Remicade Biosimilar Distributors List
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Remicade Biosimilar Product Picture
    Figure 2. Global Remicade Biosimilar Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Remicade Biosimilar Market Size 2017-2028 (US$ Million)
    Figure 4. Global Remicade Biosimilar Sales 2017-2028 (K Units)
    Figure 5. United States Remicade Biosimilar Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Remicade Biosimilar Market Size 2017-2028 (US$ Million)
    Figure 7. United States Remicade Biosimilar Sales 2017-2028 (K Units)
    Figure 8. United States Remicade Biosimilar Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Remicade Biosimilar Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Remicade Biosimilar Report Years Considered
    Figure 11. Product Picture of 100mg/10ml
    Figure 12. Product Picture of 500mg/50ml
    Figure 13. Global Remicade Biosimilar Market Share by Type in 2022 & 2028
    Figure 14. Global Remicade Biosimilar Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Remicade Biosimilar Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Remicade Biosimilar Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Remicade Biosimilar Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Remicade Biosimilar Price by Type (2017-2028) & (US$/Unit)
    Figure 19. United States Remicade Biosimilar Market Share by Type in 2022 & 2028
    Figure 20. United States Remicade Biosimilar Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Remicade Biosimilar Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Remicade Biosimilar Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Remicade Biosimilar Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Remicade Biosimilar Price by Type (2017-2028) & (US$/Unit)
    Figure 25. Product Picture of Blood Disorders
    Figure 26. Product Picture of Oncology Diseases
    Figure 27. Global Remicade Biosimilar Market Share by Application in 2022 & 2028
    Figure 28. Global Remicade Biosimilar Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 29. Global Remicade Biosimilar Sales Market Share in Value by Application (2017-2028)
    Figure 30. Global Remicade Biosimilar Sales by Application (2017-2028) & (K Units)
    Figure 31. Global Remicade Biosimilar Sales Market Share in Volume by Application (2017-2028)
    Figure 32. Global Remicade Biosimilar Price by Application (2017-2028) & (US$/Unit)
    Figure 33. United States Remicade Biosimilar Market Share by Application in 2022 & 2028
    Figure 34. United States Remicade Biosimilar Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. United States Remicade Biosimilar Sales Market Share in Value by Application (2017-2028)
    Figure 36. United States Remicade Biosimilar Sales by Application (2017-2028) & (K Units)
    Figure 37. United States Remicade Biosimilar Sales Market Share in Volume by Application (2017-2028)
    Figure 38. United States Remicade Biosimilar Price by Application (2017-2028) & (US$/Unit)
    Figure 39. North America Remicade Biosimilar Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 40. North America Remicade Biosimilar Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 41. United States Remicade Biosimilar Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Canada Remicade Biosimilar Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Europe Remicade Biosimilar Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. Europe Remicade Biosimilar Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. Germany Remicade Biosimilar Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. France Remicade Biosimilar Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. U.K. Remicade Biosimilar Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Italy Remicade Biosimilar Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Russia Remicade Biosimilar Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Asia-Pacific Remicade Biosimilar Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 51. Asia-Pacific Remicade Biosimilar Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. China Remicade Biosimilar Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Japan Remicade Biosimilar Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. South Korea Remicade Biosimilar Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. India Remicade Biosimilar Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Australia Remicade Biosimilar Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. China Taiwan Remicade Biosimilar Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Indonesia Remicade Biosimilar Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Thailand Remicade Biosimilar Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Malaysia Remicade Biosimilar Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Latin America Remicade Biosimilar Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 62. Latin America Remicade Biosimilar Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 63. Mexico Remicade Biosimilar Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Brazil Remicade Biosimilar Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Argentina Remicade Biosimilar Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Middle East & Africa Remicade Biosimilar Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 67. Middle East & Africa Remicade Biosimilar Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Turkey Remicade Biosimilar Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Saudi Arabia Remicade Biosimilar Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. UAE Remicade Biosimilar Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Remicade Biosimilar Value Chain
    Figure 72. Remicade Biosimilar Production Process
    Figure 73. Channels of Distribution
    Figure 74. Distributors Profiles
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed